Acetylsalicylic acid Completed Phase 3 Trials for Heart Valve Diseases / Cardiovascular Heart Disease / Ventricular Outflow Obstruction / Aortic Valve Stenosis / thrombotic events Diagnostic

CompletedDiagnostic3 IdentifierTitleDrugs
NCT02833948Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)